Our in vivo and in vitro functional studies establish TEFM as a candidate disease gene that should be considered in the genetic diagnostic workup of patients that present with neonatal or childhood onset mitochondrial encephalomyopathy, fatigable muscle weakness, epilepsy and variable degree of intellectual disability. This evidence concerns the gene TEFM and epilepsy.